| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total revenue | $1.57B+20.3% | $1.31B+11.9% | $1.17B+14.0% | $1.02B+11.8% | $916.2M |
| Total cost of revenue | $556.3M+37.4% | $404.8M+14.7% | $352.8M+8.3% | $325.9M+13.4% | $287.5M |
| Gross profit | $6.64B+17.9% | $5.63B+19.1% | $4.73B+12.7% | $4.20B+6.0% | $3.96B |
| Selling, general and administrative | $2.38B+11.4% | $2.14B+9.0% | $1.96B+12.9% | $1.74B+18.6% | $1.47B |
| Research and development | $1.31B+14.5% | $1.15B+14.7% | $998.8M+13.6% | $879.0M+31.0% | $671.0M |
| Total operating expenses | $3.70B+12.5% | $3.29B+10.9% | $2.96B+13.1% | $2.62B+22.5% | $2.14B |
| Income from operations | $2.95B+25.4% | $2.35B+32.9% | $1.77B+12.0% | $1.58B-13.4% | $1.82B |
| Interest and other income, net | $365.9M+12.6% | $324.9M+69.1% | $192.1M+546.8% | $29.7M-57.1% | $69.3M |
| Income before taxes | $3.31B+23.8% | $2.67B+36.5% | $1.96B+21.9% | $1.61B-15.0% | $1.89B |
| Income tax expense | $434.8M+29.3% | $336.3M+137.5% | $141.6M-46.0% | $262.4M+61.8% | $162.2M |
| Net income | $2.88B+23.1% | $2.34B+28.6% | $1.82B+35.2% | $1.34B-22.2% | $1.73B |
| Less: net income attributable to noncontrolling interest in joint venture | $20.6M+38.3% | $14.9M-22.8% | $19.3M-12.7% | $22.1M-6.0% | $23.5M |
| Net income attributable to Intuitive Surgical, Inc. | $2.86B+23.0% | $2.32B+29.2% | $1.80B+36.0% | $1.32B-22.4% | $1.70B |
| Basic (usd per share) | $8000000.00+22.3% | $6540000.00+27.7% | $5120000.00+37.6% | $3720000.00-22.3% | $4790000.00 |
| Diluted (usd per share) | $7870000.00+22.6% | $6420000.00+27.6% | $5030000.00+37.8% | $3650000.00-21.7% | $4660000.00 |
| Basic (shares) | $356.9M+0.5% | $355.2M+1.1% | $351.2M-1.3% | $355.7M-0.1% | $356.1M |
| Diluted (shares) | $362.7M+0.2% | $362.0M+1.3% | $357.4M-1.3% | $362.0M-1.0% | $365.8M |
| Joint venture | |||||
| Product | |||||
| Service | |||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.